Ceasing coverage of Vision
Recommendation
Vision Eye Institute, Australia's largest network of ophthalmology clinics, has been delisted from the ASX following its takeover by Chinese wall manufacturer Jangho Group at $1.10 per share. The stock increased 86% between Vision upgraded to Speculative Buy on 3 Mar 14 (Speculative Buy – $0.58) and our decision to Sell in New takeover offer for Vision from 14 Aug 15 (Sell – $1.08). CEASING COVERAGE
Join the Conversation...
There are 0 comments posted so far.
If you'd like to join this conversation, please login or sign up here
Interesting Facts and Q&As about this topic...
analysts@intelligentinvestor.com.au
Vision Eye Institute was delisted from the ASX following its takeover by the Chinese wall manufacturer Jangho Group. The takeover was completed at a price of $1.10 per share.
Vision Eye Institute's stock saw an 86% increase from when it was upgraded to Speculative Buy at $0.58 on March 3, 2014, to when it was recommended to Sell at $1.08 on August 14, 2015.
Vision Eye Institute was acquired by Jangho Group, a Chinese wall manufacturer.
Vision Eye Institute was taken over at a price of $1.10 per share.
Vision Eye Institute was upgraded to Speculative Buy on March 3, 2014, at a price of $0.58 per share.
The recommendation to sell Vision Eye Institute was made on August 14, 2015, at a price of $1.08 per share.
Coverage of Vision Eye Institute is ceasing because the company has been delisted from the ASX following its acquisition by Jangho Group.
Call 1300 880 160
Start a chat
Schedule a call
